Praliciguat Uses, Dosage, Side Effects and more
Praliciguat is under investigation in clinical trial NCT03254485 (A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (Hfpef)).
| Trade Name | Praliciguat |
| Generic | Praliciguat |
| Praliciguat Other Names | Praliciguat |
| Type | |
| Formula | C21H14F8N6O2 |
| Weight | Average: 534.37 Monoisotopic: 534.105049019 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
